Free Trial
LON:RLM

Realm Therapeutics (RLM) Share Price, News & Analysis

About Realm Therapeutics Stock (LON:RLM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
11.50
11.50
52-Week Range
N/A
Volume
169,853 shs
Average Volume
800,861 shs
Market Capitalization
£13.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Realm Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RLM Stock News Headlines

EPI:CA ESSA Pharma Inc.
The #1 AI Energy Stock
Nearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.
Defence of the Realm Act (DORA)
Realm Therapeutics PLC ADR (RLM_old)
See More Headlines

RLM Stock Analysis - Frequently Asked Questions

Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX) and Ampio Pharmaceuticals (AMPE).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Steel Works
Current Symbol
LON:RLM
Previous Symbol
LON:PURI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£501.92 thousand
Price / Cash Flow
0.57
Book Value
GBX 20.80 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£13.41 million
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:RLM) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners